drugset / Trial / NCT03145207
PK and DPK of Lidocaine Dermal Products
Phase 0
Completed
14 enrolled
University of Maryland, Baltimore
Food and Drug Administration (FDA) · collab
Non-randomizedCrossoverOpen-labelOther
Summary
This is a bioequivalence study to compare lidocaine release between a brand name and generic skin patches in healthy adults.
Timeline
- Start
- 2016-12-14
- Primary completion
- 2019-01-10
- Completion
- 2020-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | — | Topical |
Indications
No indication recorded.